519 related articles for article (PubMed ID: 21562776)
1. Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis.
Lina C; Conghua W; Nan L; Ping Z
J Clin Immunol; 2011 Aug; 31(4):596-605. PubMed ID: 21562776
[TBL] [Abstract][Full Text] [Related]
2. The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study.
Szalay B; Vásárhelyi B; Cseh A; Tulassay T; Deák M; Kovács L; Balog A
Clin Rheumatol; 2014 Feb; 33(2):175-85. PubMed ID: 23934385
[TBL] [Abstract][Full Text] [Related]
3. Combined use of etanercept and MTX restores CD4⁺/CD8⁺ ratio and Tregs in spleen and thymus in collagen-induced arthritis.
Huang B; Wang QT; Song SS; Wu YJ; Ma YK; Zhang LL; Chen JY; Wu HX; Jiang L; Wei W
Inflamm Res; 2012 Nov; 61(11):1229-39. PubMed ID: 22802109
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
[TBL] [Abstract][Full Text] [Related]
5. [Functional status of T helper cells in rheumatoid arthritis and effect of etanercept].
Lu TT; Zhu P; Li XY; Fan CM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):495-7. PubMed ID: 18466711
[TBL] [Abstract][Full Text] [Related]
6. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
7. A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial.
Moreland LW; O'Dell JR; Paulus HE; Curtis JR; Bathon JM; St Clair EW; Bridges SL; Zhang J; McVie T; Howard G; van der Heijde D; Cofield SS;
Arthritis Rheum; 2012 Sep; 64(9):2824-35. PubMed ID: 22508468
[TBL] [Abstract][Full Text] [Related]
8. Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.
McGovern JL; Nguyen DX; Notley CA; Mauri C; Isenberg DA; Ehrenstein MR
Arthritis Rheum; 2012 Oct; 64(10):3129-38. PubMed ID: 22674488
[TBL] [Abstract][Full Text] [Related]
9. Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion.
Guggino G; Giardina AR; Raimondo S; Giardina G; Sireci G; Dieli F; Peralta M; Alessandro R; Triolo G; Ciccia F
Clin Exp Rheumatol; 2014; 32(1):77-81. PubMed ID: 24429356
[TBL] [Abstract][Full Text] [Related]
10. Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response.
Quaglino P; Bergallo M; Ponti R; Barberio E; Cicchelli S; Buffa E; Comessatti A; Costa C; Terlizzi ME; Astegiano S; Novelli M; Cavallo R; Bernengo MG
Dermatology; 2011; 223(1):57-67. PubMed ID: 21865674
[TBL] [Abstract][Full Text] [Related]
11. Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-α therapy.
Xueyi L; Lina C; Zhenbiao W; Qing H; Qiang L; Zhu P
J Clin Immunol; 2013 Jan; 33(1):151-61. PubMed ID: 22926407
[TBL] [Abstract][Full Text] [Related]
12. Exogenous IL-2 controls the balance in Th1, Th17, and Treg cell distribution in patients with progressive rheumatoid arthritis treated with TNF-alpha inhibitors.
Kosmaczewska A; Ciszak L; Swierkot J; Szteblich A; Kosciow K; Frydecka I
Inflammation; 2015 Apr; 38(2):765-74. PubMed ID: 25145773
[TBL] [Abstract][Full Text] [Related]
13. Immunologic Parameters for Disease Activity in Rheumatoid Arthritis.
Riyadh Mohsen E; Ali NH; Aldaoseri HA
Arch Razi Inst; 2021 Oct; 76(4):1095-1105. PubMed ID: 35096346
[TBL] [Abstract][Full Text] [Related]
14. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis.
Miao J; Zhang K; Lv M; Li Q; Zheng Z; Han Q; Guo N; Fan C; Zhu P
Scand J Rheumatol; 2014; 43(3):194-201. PubMed ID: 24392804
[TBL] [Abstract][Full Text] [Related]
15. Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement.
Kosmaczewska A; Swierkot J; Ciszak L; Szteblich A; Chrobak A; Karabon L; Partyka A; Szechinski J; Wiland P; Frydecka I
Rheumatol Int; 2014 Feb; 34(2):243-53. PubMed ID: 24221190
[TBL] [Abstract][Full Text] [Related]
16. The in vitro addition of methotrexate and/or methylprednisolone determines peripheral reduction in Th17 and expansion of conventional Treg and of IL-10 producing Th17 lymphocytes in patients with early rheumatoid arthritis.
Guggino G; Giardina A; Ferrante A; Giardina G; Schinocca C; Sireci G; Dieli F; Ciccia F; Triolo G
Rheumatol Int; 2015 Jan; 35(1):171-5. PubMed ID: 24792332
[TBL] [Abstract][Full Text] [Related]
17. Regulatory immune responses induced by IL-1 receptor antagonist in rheumatoid arthritis.
Niu X; He D; Deng S; Li W; Xi Y; Xie C; Jiang T; Zhang JZ; Dong C; Chen G
Mol Immunol; 2011 Oct; 49(1-2):290-6. PubMed ID: 21943782
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of experimental rheumatoid arthritis with low-dose methotrexate by increasing partially CD4+CD25+ Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
Xinqiang S; Fei L; Nan L; Yuan L; Fang Y; Hong X; Lixin T; Juan L; Xiao Z; Yuying S; Yongzhi X
Biomed Pharmacother; 2010 Sep; 64(7):463-71. PubMed ID: 20359858
[TBL] [Abstract][Full Text] [Related]
19. Modifications in lipid levels are independent of serum TNF-α in rheumatoid arthritis: results of an observational 24-week cohort study comparing patients receiving etanercept plus methotrexate or methotrexate as monotherapy.
Rodriguez-Jimenez NA; Garcia-Gonzalez CE; Ayala-Lopez KP; Trujillo-Hernandez B; Aguilar-Chavez EA; Rocha-Muñoz AD; Vasquez-Jimenez JC; Olivas-Flores E; Salazar-Paramo M; Corona-Sanchez EG; Vazquez-Del Mercado M; Varon-Villalpando E; Cota-Sanchez A; Cardona-Muñoz EG; Gamez-Nava JI; Gonzalez-Lopez L
Biomed Res Int; 2014; 2014():510305. PubMed ID: 25243145
[TBL] [Abstract][Full Text] [Related]
20. The Expression of P2X7 Receptor on Th1, Th17, and Regulatory T Cells in Patients with Systemic Lupus Erythematosus or Rheumatoid Arthritis and Its Correlations with Active Disease.
Li M; Yang C; Wang Y; Song W; Jia L; Peng X; Zhao R
J Immunol; 2020 Oct; 205(7):1752-1762. PubMed ID: 32868411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
